Cleared Special

Volta AF-Xplorer (K232616) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K232616 · Volta Medical · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2023
Decision
30d
Days
Class 2
Risk

K232616 is an FDA 510(k) clearance for the Volta AF-Xplorer. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Volta Medical (Marseille, FR). The FDA issued a Cleared decision on September 27, 2023 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Volta Medical devices

Submission Details

510(k) Number K232616 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 28, 2023
Decision Date September 27, 2023
Days to Decision 30 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
95d faster than avg
Panel avg: 125d · This submission: 30d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 183
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K232616.
CASE V7.0 Cardiac Testing System and CardioSoft V7.0 Cardiac Testing System
K231870 · Ge Medical Systems Information Technologies, Inc. · Dec 2023
NeuTrace EP Mapping System v.2.1
K233160 · Anumana, Inc. · Nov 2023
HemoSphere Alta Advanced Monitoring Platform
K232294 · Edwards Lifesciences, LLC · Oct 2023
AVVIGO'+ Multi-Modality Guidance System
K230884 · Boston Scientific Corporation · Sep 2023
Sensis Vibe (VD15)
K223812 · Siemens Medical Solutions USA, Inc. · Sep 2023
CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00, FG-5400-00U)
K231207 · Biosense Webster, Inc. · Sep 2023